Treatment when you are not seven years old

Case-by-case, by the public record: their materials centre on children, but a 36-year-old peanut-allergic adult publicly described being accepted after meeting a component-IgE threshold (2.0 or greater in that account) and reaching maintenance within a year. Call, ask about your allergen and labs, and expect an individualised answer rather than a policy.

The published literature skews paediatric, and adult studies generally show desensitisation is achievable but with lower response rates and more dropouts than in children. That is a reason for calibrated expectations and clinician-led candidacy decisions — not a reason adults should assume the answer is no. Treating earlier in life works better; treating later still works.

The daily rules collide with adult routines: roughly two-hour rest windows around exercise and hot showers after each dose, alcohol cautions, dose timing with food, illness holds — every day, for the duration. A 36-year-old with a gym habit and work travel feels these more than a 7-year-old does. Sublingual dosing carries far lighter rules, which is a real part of why adults choose it.

Within reach of a clinic, wanting maximum supervised speed, labs supporting candidacy: a clinic OIT program is a strong option. Far from clinics, or with a schedule OIT rules would break: at-home sublingual treatment, gentler and generally somewhat slower. Wanting protection against accidental exposure without desensitisation: Xolair locally. History of anaphylaxis or unstable asthma: in-person assessment before anything, anywhere.